Research Institute for Tropical Medicine

What Research Institute for Tropical Medicine does

The Research Institute for Tropical Medicine (RITM) is a government research institute and the Philippines' National Reference Laboratory for tropical and infectious diseases, established in 1981 through Philippine-Japanese government cooperation and operating under the Department of Health. Headquartered in Muntinlupa City with a stated workforce of 1,522 personnel, RITM delivers four integrated service lines: reference laboratory diagnostics (including WHO-accredited testing for Rotavirus, Japanese Encephalitis Virus, Measles, and Rubella), clinical hospital services (in-patient and out-patient infectious disease care), national surveillance programs (notably the 35-year Antimicrobial Resistance Surveillance Program across 24 sentinel sites), and capacity building (RITM NEQAS proficiency testing, Learning and Development Information System, COVID-19 Quality Assurance Program for a national network of 279 licensed testing laboratories).

RITM's underlying technology stack is conventional molecular and microbiological: Real-Time RT-PCR for SARS-CoV-2 detection, Oxford Nanopore third-generation sequencing (deployed via University of Glasgow partnership), aerobic culture and antimicrobial susceptibility testing, and biosafety level 3 containment. Seven subnational laboratories established in 2022 across Ilocos, Central Luzon, Western Visayas, Central Visayas, Zamboanga, Davao, and Cotabato extend the institute's physical footprint beyond the Muntinlupa headquarters into regional medical centers.

Revenue mechanics are entirely public-sector: annual DOH appropriations form the core budget, PhilHealth reimburses laboratory testing on behalf of patients with no co-payment required, and multilateral grants from WHO and the World Bank support capital and emergency response programs. End-customers are exclusively government entities—regional hospitals, licensed public and private testing laboratories operating under DOH mandate, and medical technologists trained through RITM's certificate-issuing programs. The institute has no private commercial revenue stream and operates as public health infrastructure rather than a market-facing enterprise.

Name

Research Institute for Tropical Medicine

Legal name

Research Institute for Tropical Medicine

Website

https://ritm.gov.ph

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Research Institute for Tropical Medicine is the Philippines' government-run National Reference Laboratory and National Referral Center for emerging and re-emerging infectious diseases under the Department of Health, providing diagnostic testing, AMR surveillance, and laboratory quality assurance to a national network of 279 licensed testing laboratories and seven regional hospitals.

Ownership category

akta.pro rank

Product category

Public Health Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

akta.pro secondary industries

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Regional/State Public Health Laboratories (HLAJAIAB), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)

Keywords

• Infectious disease diagnostics
• Public health reference laboratory
• Antimicrobial resistance surveillance
• Clinical microbiology testing
• Laboratory capacity building

Headquarters

HQ city

Muntinlupa City

HQ country

Philippines

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Government Funding: As a Department of Health-attached agency, RITM operates primarily through annual government appropriations and special budget allocations for specific programs such as COVID-19 emergency response
2. PhilHealth Reimbursements: Laboratory testing services are subsidized and reimbursed through PhilHealth (Philippine Health Insurance Corporation) with no extra charges imposed on patients

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

RITM serves as the Philippines' National Reference Laboratory and National Referral Center for Emerging and Re-emerging Infectious Diseases, delivering confirmatory diagnostic testing, infectious disease surveillance, clinical care, and laboratory training. It operates a national proficiency testing scheme (RITM NEQAS), runs the Antimicrobial Resistance Surveillance Program (ARSP) across 24 sentinel sites, conducts research on tropical diseases, and provides hospital inpatient and outpatient services for infectious disease cases.

Product overview

The Research Institute for Tropical Medicine (RITM) is a government research institute and National Reference Laboratory offering a comprehensive portfolio of diagnostic, surveillance, training, and research services. As the Philippines' WHO-accredited National Reference Laboratory for Rotavirus, Japanese Encephalitis Virus, Measles, and Rubella Virus, RITM provides COVID-19 RT-PCR testing services, operates the RITM NEQAS proficiency testing program for multiple disciplines, and conducts antimicrobial resistance surveillance through the ARSP. Core offerings include microbiology and molecular diagnostic laboratory services, hospital inpatient/outpatient care, training and capacity building programs, COVID-19 kit evaluation, and infectious disease research. The institute also provides certificate verification through its Learning and Development Information System (LDIS) and maintains online appointment scheduling for testing services.

Differentiator

Problem solved

Functional benefit

Products and services

• COVID-19 Testing Services

Quantifiable outcome

• Established 7 subnational laboratories for vaccine-preventable diseases across the Philippines, expanding testing capacity to multiple regions
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

13 partnerships are on record, tiered core and flagship.

• World Health Organization (WHO)coreStrategic or Co-development Partner · 20 January 2022WHO supports RITM through equipment and supplies donations (P36 million+) for establishing seven subnational laboratories for vaccine-preventable diseases. RITM serves as WHO-accredited National Reference Laboratory for multiple diseases and contributes data to WHO Global Antimicrobial Surveillance System (GLASS).
• Ilocos Training and Regional Medical CentercoreStrategic or Co-development Partner · 20 January 2022One of seven regional health facilities designated as subnational laboratory for vaccine-preventable diseases (measles, rubella, rotavirus, Japanese encephalitis) to expand confirmatory testing capacity across the Philippines.
• Jose B. Lingad Memorial Regional HospitalcoreStrategic or Co-development Partner · 20 January 2022Designated subnational laboratory for vaccine-preventable diseases in Central Luzon region, part of RITM-led national laboratory network expansion.
• Western Visayas Medical CentercoreStrategic or Co-development Partner · 20 January 2022Subnational laboratory designation for vaccine-preventable diseases in Western Visayas region.
• Vicente Sotto Memorial Medical CentercoreStrategic or Co-development Partner · 20 January 2022Subnational laboratory for vaccine-preventable diseases in Central Visayas; also recognized as Best Sentinel Site for ARSP 2021.
• Zamboanga Medical CentercoreStrategic or Co-development Partner · 20 January 2022Subnational laboratory designation for vaccine-preventable diseases in Zamboanga Peninsula region.
• Southern Philippines Medical CentercoreStrategic or Co-development Partner · 20 January 2022Subnational laboratory for vaccine-preventable diseases in Davao Region.
• Cotabato Regional and Medical CentercoreStrategic or Co-development Partner · 20 January 2022Subnational laboratory designation for vaccine-preventable diseases in Cotabato Region.
• University of GlasgowflagshipStrategic or Co-development Partner · 19 August 2020Collaboration with experts from University of Glasgow, Scotland, UK for third-generation sequencing technology to release SARS-CoV-2 genome sequences from Philippine cases. First 17 viral genome sequences released through this partnership.
• United Kingdom Medical Research Council (UK-MRC)flagshipStrategic or Co-development Partner · 1 January 2013Funding for Monkeybar Project investigating Plasmodium knowlesi (monkey malaria) transmission. 5-year research project with Malaysia and UK partners using ecohealth approach combining primatology, entomology, and sociology.
• Department of Health (DOH)coreStrategic or Co-development PartnerRITM operates as an attached agency under DOH, serving as the National Referral Center for Emerging and Re-emerging Infectious Diseases and National Reference Laboratory for various diseases. DOH provides overarching policy direction and funding support.
• The Love Yourself FoundationcoreStrategic or Co-development PartnerPartnership for HIV prevention among MSM community through online interventions, peer education (change agents), and continuum of care model. RITM Satellite Clinic operated in partnership provides HIV testing and treatment linkage services.
• Japan National Institute of Infections Disease (NIID)coreStrategic or Co-development PartnerCollaborative research on rabies diagnostic alternatives (DRIT) and molecular epidemiology of rabies viruses for improving mass vaccination strategies in the Philippines.

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• National Institute of Infectious Diseases (Japan): Japan's national infectious disease reference laboratory, comparable to RITM as a government-affiliated NRL with WHO-designated functions. RITM partners with NIID on rabies diagnostics (DRIT) and molecular epidemiology.
• Liverpool School of Tropical Medicine: Long-established tropical medicine research and teaching institution with reference laboratory and surveillance roles. Directly comparable to RITM's tropical disease research, training, and clinical trial capabilities.
• Mahidol Oxford Tropical Medicine Research Unit (MORU): Thailand-based tropical medicine research unit with direct overlap to RITM in malaria research, clinical trials, and regional infectious disease studies. Comparable in scope as an academic-government collaborative in tropical medicine.
• Bernhard Nocht Institute for Tropical Medicine: Germany's national reference center for tropical pathogens, combining diagnostic reference laboratory services with research and training. Comparable to RITM as a government-affiliated tropical medicine institute with reference laboratory functions.
• Swiss Tropical and Public Health Institute: Swiss institute combining tropical medicine research, diagnostic reference services, and public health capacity building. Comparable to RITM's integrated research-reference-training model with strong international partnerships.

Broad incumbents

• Institut Pasteur: Global network of biomedical research institutes with national reference laboratory functions in infectious diseases. Comparable to RITM in mandate (research, reference lab, surveillance, training) but operates at much larger international scale.
• U.S. Centers for Disease Control and Prevention (CDC): U.S. national public health agency with comprehensive infectious disease surveillance, reference laboratory, and global health capacity-building functions. Comparable as a broad incumbent across RITM's full mission scope.
• Indian Council of Medical Research (ICMR): India's apex body for biomedical research with national reference laboratory network for infectious diseases. Comparable to RITM in scale and government-affiliated mandate, but serves a larger and more decentralized national footprint.

Regional players

• Eijkman Institute for Molecular Biology: Indonesia's molecular biology and infectious disease research institute. Regional peer to RITM in tropical disease research, AMR surveillance, and government-affiliated reference laboratory functions within Southeast Asia.
• Institut Pasteur du Cambodge: Cambodia-based Pasteur Institute with infectious disease reference laboratory and surveillance functions. Regional Southeast Asia peer to RITM with similar mandate in tropical disease diagnostics and research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ritmph
• Facebookfacebook.com/RITMPH

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research Institute for Tropical Medicine